UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
For the month of September 2025
Commission File Number: 001-41425
金太阳健康科技集团有限公司
(Translation of registrant’s name into English)
Golden Sun Health Technology Group Limited
Room 503, Building C2, No. 1599
Xinjinqiao Road, Pudong New Area
Shanghai, China
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Resignation and Appointment of Chief Operating
Officer
On September 18, 2025, Ms. Xiaoyi Wang resigned
as the Chief Operating Officer (“COO”) of Golden Sun Health Technology Group Limited (the “Company”), effective
on September 18, 2025. Ms. Wang’s resignation was due to personal reasons and was not the result of any disputes or disagreement
with the Company or its board of directors on any matter relating to the Company’s operations, policies or practices.
On September 23, 2025, the board of directors
of the Company appointed Mr. Duo Ye as COO of the Company, effective on September 18, 2025, to fill in the vacancy.
Mr. Duo Ye has extensive
experience in the financial services and media industries, with over a decade in senior management roles. From November 2023 to
September 2025, he was the General Manager at Zhejiang Jintaiyang Selection Technology Co., Ltd., a company focused on cross border
e-commerce, cultural and tourism planning services, and information technology services. From December 2020 to October 2023, he
served as Chief Operating Officer of Jinhua Single Dog Culture Media Co., Ltd., a company primarily engaged in cultural tourism
planning services, information technology services, and online live streaming expert training. Between October 2014 to October 2020,
he served as General Manager of Shanghai Nuoxin Asset Management Co., Ltd., a company focused on asset management and industrial
investment, and between December 2010 to October 2014, he served as Deputy General Manager of the Institutional Business Department
at Xinhua Trust Co., Ltd., a company primarily engaged in trust and fund business. Earlier in his career, he served as a Branch
Manager at the Daikoku Hotel Group in New Zealand, a company focused on accommodation and catering services. Mr. Ye received an MBA
from the City University of Macau in Macau in 2016 and a diploma in hospitality from Auckland Wise Institute in Auckland in
2006.
On September 24, 2025, the Company entered
into an employment agreement with Mr. Ye, pursuant to which Mr. Ye is entitled to receive a monthly salary of $3,233, plus standard
employee benefits granted by the Company. The term of this agreement is three years, commencing from September 18, 2025 to September
17, 2028, subject to automatic renewal unless a two-month advance notice by either party to terminate the agreement prior to the
expiration of such term, or early termination by either party pursuant to the terms of the agreement. The Company may terminate the
employment for cause, at any time, without notice or remuneration, for certain acts of the executive officer, including but not
limited to the commitments of any serious or persistent breach or non-observance of the terms and conditions of the employment,
conviction of a criminal offense, willful disobedience of a lawful and reasonable order, fraud or dishonesty, receipt of bribery, or
severe neglect of his duties. The agreement also contains customary covenants related to confidentiality and
non-disclosure.
There are no family relationships between Mr.
Ye and any director or executive officer of the Company. There are no transactions between the Company and Mr. Ye that are subject to
disclosure under Item 404(a) of Regulation S-K.
The foregoing description of the employment agreement
with Mr. Ye is a summary only and does not purport to be complete, and is qualified in its entirety by reference to the full text of such
document, the form of which is attached hereto as Exhibit 10.1, and incorporated herein by reference.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
| |
Golden Sun Health Technology Group Limited |
| |
|
|
| |
By: |
/s/ Xueyuan Weng |
| |
|
Name: |
Xueyuan Weng |
| |
|
Title: |
Chief Executive Officer |
Date:
September 24, 2025
EXHIBIT INDEX
| Exhibit Number |
|
Description |
| 10.1 |
|
Employment Agreement, dated September 24, 2025, between the Company and Duo Ye. |
3
